|
|
||||||||





* Department of Medicine/Immunobiology Program, University of Vermont, Burlington, VT 05405;
Department of Veterinary and Animal Sciences, University of Massachusetts Amherst, Amherst, MA 01003;
Division of Hematology and Oncology, Ohio State University, Columbus, OH 43210;
Trudeau Institute, Saranac Lake, NY 12983; and
¶ Department of Biochemistry, State University of New York, Buffalo, NY 14241
IP3 (inositol 1,4,5-trisphosphate) receptors (IP3Rs) regulate the release of Ca2+ from intracellular stores in response to IP3. Little is known about regulation of the expression of IP3Rs and their role during the activation of CD4 T cells. In this study we show that mouse naive CD4 T cells express IP3R1, IP3R2, and IP3R3, but that gene expression of IP3R3 primarily is down-regulated upon activation due to loss of the Ets-1 transcription factor. Down-regulation of IP3R expression in activated CD4 T cells is associated with the failure of TCR ligation to trigger Ca2+ release in these cells. We also show that down-regulation of specific IP3Rs in activated CD4 T cells correlates with the requirement of IP3R-mediated Ca2+ release only for the induction of, but not for the maintenance of, IL-2 and IFN-
expression. Interestingly, while inhibition of IP3R function early during activation blocks IL-2 and IFN-
production, it promotes the production of IL-17 by CD4 T cells. Thus, IP3Rs play a key role in the activation and differentiation of CD4 T cells. The immunosuppressive effect of pharmacological blockers of these receptors may be complicated by promoting the development of inflammatory CD4 T cells.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by a National Institutes of Health Program Project Grant P02AI045666 (to M.R.) and the Centers of Biomedical Research Excellence Program of the National Center for Research Resources (RR15557) (to M.R.).
2 Address correspondence and reprint requests to Dr. Mercedes Rincon, Department of Medicine/Immunobiology Program, Given Medical Building D-305, University of Vermont, Burlington, VT 05405. E-mail address: mrincon{at}uvm.edu
3 Abbreviations used in this paper: IP3, inositol 1,4,5-trisphosphate; 2-APB, 2-aminoethoxydiphenyl borate; ChIP, chromatin immunoprecipitation; CRAC, Ca2+ release-activated Ca2+; IP3R, IP3 receptor; RPA, RNase protection assay; Xe-C, xestospongin C.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |